More than 94,000 people in the United States were waiting for a kidney transplant as of December 1, 2025. Many of them will wait years. Some will not survive the wait. That reality is exactly why a new development out of the University of Southern California is drawing serious attention from the medical community — and from anyone who has ever watched a loved one spend hours tethered to a dialysis machine.
Researchers at USC say they have successfully created long-lasting nephron progenitor cells from human stem cells and used those cells to form kidney organoids — miniature, three-dimensional kidney structures grown in the lab. It is not a transplant-ready artificial kidney. But scientists argue it is a meaningful and durable step toward one.
The work points toward a future where chronic kidney disease — which currently affects more than one in seven U.S. adults — might be treated with tools that simply do not exist yet. Understanding what was actually achieved, and what it means for patients, requires a closer look at the biology involved.
What Scientists Actually Built — and Why It’s Different
The kidney is one of the body’s most architecturally complex organs. Each kidney contains roughly one million nephrons, the microscopic filtering units responsible for cleaning blood, removing waste, and keeping the body’s water and mineral levels in balance. When nephrons fail, they do not regenerate. The damage is permanent.
Nephron progenitor cells are the biological starting point for building nephrons. They are the early-stage cells that, during fetal development, give rise to the entire nephron structure. The challenge researchers have faced for years is that these cells are notoriously difficult to grow in a lab setting — they tend to lose their identity and functionality over time.
What the USC team reports achieving is a method for creating nephron progenitor cells that are notably long-lasting and stable. The word researchers used matters here: these cells are described as self-renewing, meaning they can sustain themselves in lab conditions rather than burning out quickly. That durability is what makes them more scalable — and more useful — than what was previously available.
From those stable progenitor cells, the team was able to generate kidney organoids: small, three-dimensional structures that mimic aspects of real kidney tissue. These are not functional kidneys. But they are far more sophisticated research tools than a flat layer of cells on a dish.
The Scale of the Problem These Cells Could Help Solve
To understand why this matters beyond academic circles, consider the numbers surrounding kidney disease in the United States alone.
| Statistic | Figure |
|---|---|
| U.S. adults affected by chronic kidney disease | More than 1 in 7 |
| People on the U.S. kidney transplant waiting list (as of Dec. 1, 2025) | 94,015 |
| Nephrons in each human kidney | Approximately 1 million |
Dialysis — the mechanical process of filtering blood outside the body — keeps people alive when kidneys fail, but it is not a cure. Patients typically undergo sessions multiple times per week, each lasting several hours. The physical and emotional toll is significant, and dialysis does not replicate everything a healthy kidney does.
A transplant is the closest thing medicine currently has to a real solution, but donor organs are scarce. The gap between supply and demand has remained stubbornly wide for decades, which is why the field of regenerative medicine has been working toward lab-grown alternatives.
What Kidney Organoids Can Actually Do Right Now
Even without being transplant-ready, kidney organoids grown from stable nephron progenitor cells have real and immediate value. Researchers point to three areas where this technology could make a practical difference relatively soon.
- Studying kidney development: Organoids allow scientists to watch how kidney structures form and identify where that process goes wrong in genetic diseases.
- Modeling genetic disorders: Patient-derived stem cells can be used to create organoids that carry the same genetic mutations as the patient, giving researchers a direct window into how a specific disease behaves at the cellular level.
- Drug testing: Testing potential kidney treatments on organoids that closely mimic real kidney tissue offers more precision than older lab methods — and could reduce the need for animal testing in early research stages.
Each of these applications benefits directly from the durability of the cells the USC team developed. A more stable, scalable starting material means more consistent results, larger experiments, and ultimately more reliable data.
How Far Away Is an Actual Artificial Kidney?
Researchers are careful to frame this work accurately. The creation of long-lasting nephron progenitor cells and kidney organoids does not mean lab-grown kidneys suitable for transplant are imminent. The leap from a small organoid to a fully vascularized, functioning organ that can be implanted into a human body involves challenges that remain unsolved.
What this work does is strengthen the foundation. A more reliable supply of the right starting cells makes every subsequent step — including efforts to eventually build larger, more complex kidney structures — more feasible. Scientists describe this as providing a sturdier, more scalable pathway for kidney research, not an endpoint in itself.
The field of regenerative medicine has seen steady, incremental progress over the past decade, and kidney science is no exception. Each advance tends to enable the next one. The USC development fits that pattern: it solves a specific, stubborn problem — cell instability in the lab — and in doing so, opens doors that were previously harder to push through.
For the tens of millions of people living with chronic kidney disease, and for the more than 94,000 waiting for a transplant, the timeline still feels frustratingly long. But the direction of travel is clear, and the tools researchers are working with are getting meaningfully better.
Frequently Asked Questions
What did USC researchers actually create?
Scientists at the University of Southern California created long-lasting nephron progenitor cells from human stem cells and used them to form kidney organoids — miniature 3D kidney structures grown in a laboratory setting.
Does this mean lab-grown kidneys for transplant are ready soon?
No. Researchers are clear that transplant-ready lab kidneys are not immediately around the corner. This work represents a foundational step, not a finished product.
What are nephron progenitor cells?
They are early-stage kidney cells that serve as the biological starting material for building nephrons, the filtration units inside each kidney. Each human kidney contains approximately one million nephrons.
How many people are affected by kidney disease in the U.S.?
Chronic kidney disease affects more than one in seven U.S. adults, and as of December 1, 2025, there were 94,015 people on the U.S. kidney transplant waiting list.
What can kidney organoids be used for right now?
They can be used to study kidney development, model genetic disorders, and test potential drug treatments with greater precision than older laboratory methods.
Why were stable nephron progenitor cells so difficult to create before?
These cells have historically been difficult to sustain in lab conditions because they tend to lose their identity and function over time. The USC team’s advance involves creating cells that are more durable and self-renewing, making them more practical for large-scale research.
Leave a Reply